Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
clinical trials
life sciences
national blog main
national top stories
new york top stories
abbvie
acorda therapeutics
ampyra
apokyn
apomorphine
billy dunn
biogen
biotech
boston blog main
boston top stories
dalfampridine
drug prices
drug pricing
duopa
europe top stories
evrysdi
fda
gene therapy
genentech
inbrija
ionis pharmaceuticals
mylan
national
new york
new york blog main
novartis
nusinersen
parkinson's disease
paul matteis
risdiplam
rna drugs
roche
san francisco top stories
spinal muscular atrophy
spinraza
What
approved
2
×
drug
fda
friday
2
×
new
patients
2
×
acorda
atrophy
cope
daily
disease
episodes
evrysdi
gets
green
help
home
intended
late
lights
liquid
looms
meant
medications
medicine
muscular
nod
oral
parkinson’s
risdiplam
rival
roche
spinal
stop
therapy
treatment
working
Language
unset
Current search:
friday
×
patients
×
approved
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
5 years ago
Acorda Gets FDA Nod For New Parkinson’s Drug, But Rival Looms